Author

Debanjali Purkayastha

Observed name: Purkayastha, Debanjali

Observed institutions: University of Waterloo, Ottawa Hospital, McGill University

OpenAlex ID: A5040958653

Drug-drug interactions with CFTR modulator therapy in cystic fibrosis: Focus on Trikafta®/Kaftrio®

2023 · Debanjali Purkayastha, Kyla Agtarap, et al. · Journal of Cystic Fibrosis · 33

Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews

2022 · Salmaan Kanji, Sydney Morin, et al. · Drugs · 17

Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic review

2023 · Arvind Grewal, Pierre Thabet, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 6

Implementation and evaluation of a continuous infusion protocol for piperacillin-tazobactam and meropenem in critically ill adult patients with septic shock

2024 · Purkayastha, Debanjali, Thabet, Pierre, et al. · TSpace (University of Toronto)

Strategies to develop and implement a protocol for prolonged infusions of beta-lactam antibiotics in an inpatient setting: A scoping review

2023 · Saunders, Hannah, Richler, Caitlin, et al. · TSpace (University of Toronto)

Trump’s global gag rule and its impact on maternal health worldwide

2018 · Beitari, Saina, Heer, Emily, et al. · McGill Journal of Global Health

Works count: 7

Citation count: 56

H-index: 3

I10-index: 2